Literature DB >> 11318524

A long-term follow-up analysis of serial core promoter and precore sequences in Japanese patients chronically infected by hepatitis B virus.

Y Kajiya1, K Hamasaki, K Nakata, S Miyazoe, Y Takeda, S Higashi, K Ohkubo, T Ichikawa, K Nakao, Y Kato, K Eguchi.   

Abstract

To investigate the association of hepatitis B virus (HBV) with core promoter mutation (T1762A1764) or precore mutation (A1896) with the clinical course of illness, we analyzed serial core promoter and precore sequences in 22 patients with HBV-associated chronic liver disease who were followed for 12+/-4 years (mean +/- SD). Sixteen of 22 patients were positive for HBeAg at baseline, and 15 of the 16 patients seroconverted to anti-HBe during the observation period. T1762A1764 mutation was detected in 16 of 22 patients, including 11 patients positive for HBeAg, at baseline. During the follow-up period, A1896 mutation emerged in 7 of 16 patients who had the wild-type HBV or only the T1762A1764 mutation at baseline. Sustained remission of hepatitis correlated with the low level of viremia, but did not with type of mutations. These results indicate that HBV with T1762A1764 mutation tends to precede A1896 mutation during the course of infection in Japanese patients with chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318524     DOI: 10.1023/a:1005582812466

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method.

Authors:  M Lindh; A S Andersson; A Gusdal
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

2.  Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily.

Authors:  X Yu; J E Mertz
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion.

Authors:  H L Chan; M Hussain; A S Lok
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

4.  Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.

Authors:  V E Buckwold; Z Xu; M Chen; T S Yen; J H Ou
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

Authors:  K Moriyama; H Okamoto; F Tsuda; M Mayumi
Journal:  Virology       Date:  1996-12-15       Impact factor: 3.616

6.  Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection.

Authors:  A Nagasaka; S Hige; M Marutani; I Tsunematsu; M Saito; Y Yamamoto; S Konishi; M Asaka
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

7.  The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection.

Authors:  K Takahashi; K Aoyama; N Ohno; K Iwata; Y Akahane; K Baba; H Yoshizawa; S Mishiro
Journal:  J Gen Virol       Date:  1995-12       Impact factor: 3.891

8.  Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal.

Authors:  A S Lok; U Akarca; S Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression.

Authors:  T F Baumert; A Marrone; J Vergalla; T J Liang
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.

Authors:  F Bonino; F Rosina; M Rizzetto; R Rizzi; E Chiaberge; R Tardanico; F Callea; G Verme
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

View more
  7 in total

1.  High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter.

Authors:  Xiao-Mou Peng; Gui-Mei Huang; Jian-Guo Li; Yang-Su Huang; Yong-Yu Mei; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

2.  Histological grading and staging of liver and its relation to viral loads in chronic anti-HBe positive hepatitis.

Authors:  Shahriar Shafaei; Shima Soleimani Amiri; Mahmoud Hajiahmadi; Mahmoud Sadeghi-Haddad-Zavareh; Masomeh Bayani
Journal:  Caspian J Intern Med       Date:  2013

3.  Evaluation of the need for treatment on 72 subjects with anti-HBe positive chronic hepatitis B.

Authors:  Shima Soleimani Amiri; Shariar Shafaee; Mohammad Reza Hasanjani Roushan; Masomeh Baiani; Mahmoud Hajiahmadi
Journal:  Caspian J Intern Med       Date:  2012

Review 4.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

5.  Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression.

Authors:  Dake Zhang; Sufang Ma; Xin Zhang; Hanqing Zhao; Huiguo Ding; Changqing Zeng
Journal:  BMC Infect Dis       Date:  2010-09-16       Impact factor: 3.090

6.  Mutation profiling of the hepatitis B virus strains circulating in North Indian population.

Authors:  Amit Tuteja; Abu Baker Siddiqui; Kaushal Madan; Rohit Goyal; Vishnubhatla Sreenivas; Navkiran Kaur; Subrat K Panda; Krishnamoorthy Narayanasamy; Swati Subodh; Subrat K Acharya
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

7.  Molecular epidemiology and clinical characteristics of hepatitis B identified through the French mandatory notification system.

Authors:  Vincent Thibault; Syria Laperche; Valérie Thiers; Sophie Sayon; Marie-José Letort; Elisabeth Delarocque-Astagneau; Denise Antona
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.